Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years

BACKGROUND: Stereotactic body radiotherapy (SBRT) may yield disease control for prostate cancer in a brief, hypofractionated treatment regimen without increasing treatment toxicity. Our report presents a 6-year update from 304 low- (n = 211), intermediate- (n = 81), and high-risk (n = 12) prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Alan J, Santoro, Michael, Diblasio, Fred, Ashley, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674983/
https://www.ncbi.nlm.nih.gov/pubmed/23668632
http://dx.doi.org/10.1186/1748-717X-8-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674983/
https://www.ncbi.nlm.nih.gov/pubmed/23668632
http://dx.doi.org/10.1186/1748-717X-8-118

Ejemplares similares